Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.

The secretory nature of NETs implies the determination of the CgA concentration as a standard marker. The concentration of CgA in plasma correlates with the degree of histopathological differentiation, tumor stage, and is an essential prerequisite for therapy. A retrospective analysis of the results...

Full description

Bibliographic Details
Main Authors: A Malecha-Jędraszek, H Donica, E Strosławska, A Burska, F Szubstarski
Format: Article
Language:English
Published: Via Medica 2011-04-01
Series:Folia Histochemica et Cytobiologica
Online Access:http://czasopisma.viamedica.pl/fhc/article/view/4184
_version_ 1817976497071194112
author A Malecha-Jędraszek
H Donica
E Strosławska
A Burska
F Szubstarski
author_facet A Malecha-Jędraszek
H Donica
E Strosławska
A Burska
F Szubstarski
author_sort A Malecha-Jędraszek
collection DOAJ
description The secretory nature of NETs implies the determination of the CgA concentration as a standard marker. The concentration of CgA in plasma correlates with the degree of histopathological differentiation, tumor stage, and is an essential prerequisite for therapy. A retrospective analysis of the results of the plasma CgA concentrations in relation to histopathological and clinical findings (type of NET according to the WHO classification, severity of disease based on the presence of metastases and clinical symptoms) as well as somatostatin receptor scintigraphy was performed in 41 patients with NET. The patients were treated in The Regional Oncology of Lublin from February 2005 to May 2008. Data from the literature and results of this study suggest the use of CgA in the diagnosis and prognosis of NET. Plasma CgA concentration analysed together with histopathological assessment of tumor and the clinical picture is a useful marker in the diagnosis of neuroendocrine tumours. High plasma CgA concentrations may indicate the presence of highly-differentiated NET (WDNEC), and also may indicate the presence of tumor metastasis. The highest CgA concentrations were observed in patients with neuroendocrine tumors associated with carcinoid symptoms and the presence of metastases to the liver.
first_indexed 2024-04-13T22:04:18Z
format Article
id doaj.art-b52aea67804c4032ae87548d7460c0d0
institution Directory Open Access Journal
issn 0239-8508
1897-5631
language English
last_indexed 2024-04-13T22:04:18Z
publishDate 2011-04-01
publisher Via Medica
record_format Article
series Folia Histochemica et Cytobiologica
spelling doaj.art-b52aea67804c4032ae87548d7460c0d02022-12-22T02:27:59ZengVia MedicaFolia Histochemica et Cytobiologica0239-85081897-56312011-04-0148460361010.5603/4184Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.A Malecha-JędraszekH DonicaE StrosławskaA BurskaF SzubstarskiThe secretory nature of NETs implies the determination of the CgA concentration as a standard marker. The concentration of CgA in plasma correlates with the degree of histopathological differentiation, tumor stage, and is an essential prerequisite for therapy. A retrospective analysis of the results of the plasma CgA concentrations in relation to histopathological and clinical findings (type of NET according to the WHO classification, severity of disease based on the presence of metastases and clinical symptoms) as well as somatostatin receptor scintigraphy was performed in 41 patients with NET. The patients were treated in The Regional Oncology of Lublin from February 2005 to May 2008. Data from the literature and results of this study suggest the use of CgA in the diagnosis and prognosis of NET. Plasma CgA concentration analysed together with histopathological assessment of tumor and the clinical picture is a useful marker in the diagnosis of neuroendocrine tumours. High plasma CgA concentrations may indicate the presence of highly-differentiated NET (WDNEC), and also may indicate the presence of tumor metastasis. The highest CgA concentrations were observed in patients with neuroendocrine tumors associated with carcinoid symptoms and the presence of metastases to the liver.http://czasopisma.viamedica.pl/fhc/article/view/4184
spellingShingle A Malecha-Jędraszek
H Donica
E Strosławska
A Burska
F Szubstarski
Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
Folia Histochemica et Cytobiologica
title Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
title_full Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
title_fullStr Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
title_full_unstemmed Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
title_short Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
title_sort significance of plasma chromogranin a determination in neuroendocrine tumour net diagnosis
url http://czasopisma.viamedica.pl/fhc/article/view/4184
work_keys_str_mv AT amalechajedraszek significanceofplasmachromograninadeterminationinneuroendocrinetumournetdiagnosis
AT hdonica significanceofplasmachromograninadeterminationinneuroendocrinetumournetdiagnosis
AT estrosławska significanceofplasmachromograninadeterminationinneuroendocrinetumournetdiagnosis
AT aburska significanceofplasmachromograninadeterminationinneuroendocrinetumournetdiagnosis
AT fszubstarski significanceofplasmachromograninadeterminationinneuroendocrinetumournetdiagnosis